Google Search

Search

Already a Member ?

Investment Opportunities & Business Ideas in Ghana, West Africa - Identification and Selection of right Project, Thrust areas for Investment, Industry Startup and Entrepreneurship Projects

We can provide you detailed project reports on the following topics. Please select the projects of your interests.

Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.

We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.

Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.

We can modify the project capacity and project cost as per your requirement.
We can also prepare project report on any subject as per your requirement.

Page 160 of 161 | Total 1602 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 .... 160 161   Next »

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Select all | Clear all Sort by

Bleaching Powder

Bleaching powder is calcium hypochlorite ( Ca(OCl)2 ). Bleaching powder is a white - yellowish powder which very well dissolves in water. It is a one of the major chemical industry in the world. Limestone and chlorine gas are used as raw materials to manufacture bleaching powder which is used as a disinfectant and as an oxidizing agent. It is an inorganic compound. Bleaching powder is one of the most widely used bleaching, sanitation and disinfecting agents in the world. Bleaching powder is considered to be the best product to be used in swimming pool water treatment. As a mixture with lime and calcium chloride, it is marketed as chlorine powder for water treatment and as a bleaching agent. Calcium hypochlorite is an integral component of bleaching powder which also includes calcium chloride and slaked lime. Calcium hypochlorite is the second most used chemical type in the hypochlorite market; sodium hypochlorite (liquid bleach) being the most used type. Bleaching powder is extensively used as a chlorine compound, which is highly effective against several micro organisms such as algae, bacteria, fungi, slime and other harmful and unwanted micro-organisms which exist in the environment. The market is primarily driven by its use in swimming pools, hot tub water and spas. It is used in the swimming pools to kill thriving micro organisms which pose a threat to human health and also to prevent contamination. Strong solutions of Bleaching powder are used to disinfect and sanitize pool sides, pool bottom, diving boards, decks, ladders and other surfaces. It is also extensively used to treat waste water and disinfect sewages. It is commonly used as a bleaching agent and also finds application as industrial sanitizer. Characteristics of bleaching powder • Bleaching powder is a pale yellowish powder existing with a strong smell of chlorine. • It is soluble in water but due to the presence of impurities. • Its chemical formula is CaOCl2 with its chemical name as Calcium hypochlorite. Uses: • As a disinfectant and germicide especially in the sterilization of drinking water. • For the manufacture of chloroform. • For making wool unshrinkable. • As an oxidising agent in the industry. The global Bleaching Powder market is anticipated to rise at a considerable rate during the forecast period, between 2020 and 2026. In 2020, the market was growing at a steady rate and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon. The Bleaching Powder market provides a bird’s eye view of the current proceeding within the Bleaching Powder market. Further, the impact of the novel COVID-19 pandemic on the Bleaching Powder market and offers a clear assessment of the projected market fluctuations during the forecast period. The different factors that are likely to impact the overall dynamics of the Bleaching Powder market over the forecast period (2019-2029) including the current trends, growth opportunities, restraining factors etc. The key players of the market are Swastik Chemicals, Olin Chlor Alkali, Aditya Birla Chemicals, Lords Chloro Alkali Limited, GACL, Sree Rayalaseema Hi-Strength Hypo Ltd, Suvidhi Industries, OxyChem, Kuehne, Clorox, Hill Brothers Chemical, Vertex Chemical, HASA etc.
Plant capacity: -Plant & machinery: 1
Working capital: N/AT.C.I: 00
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Solar Panel

Solar panel refers either to a photovoltaic module, a solar thermal energy panel, or to a set of solar photovoltaic (PV) modules electrically connected and mounted on a supporting structure. A PV module is a packaged, connected assembly of solar cells. Solar panels can be used as a component of a larger photovoltaic system to generate and supply electricity in commercial and residential applications. Each module is rated by its DC output power under standard test conditions (STC), and typically ranges from 100 to 320 watts. The efficiency of a module determines the area of a module given the same rated output - an 8% efficient 230 watt module will have twice the area of a 16% efficient 230 watt module. There are a few solar panels available that are exceeding 19% efficiency. A single solar module can produce only a limited amount of power most installations contain multiple modules. A photovoltaic system typically includes a panel or an array of solar modules, an inverter, and sometimes a battery and/or solar tracker and interconnection wiring. India solar power products market is projected to grow at a CAGR of more than 11% to surpass $ 7.6 billion by 2024 on the back of increasingly stringent policy and regulatory framework and rising environmental concerns. The Ministry of New and Renewable Energy has set a target of 100 GW of solar power generation capacity by 2022. To achieve the target, government has taken several initiatives in the form of offering subsidies, financial assistance, incentives to manufacturers, power producers and even customers. The government has also partnered with several nodal agencies at the central and state levels for the installation of off-grid SPV systems. Subsidies are made available to the customers to encourage installation of grid connected rooftop photovoltaics. Additionally, rising per capita income and developments in the photovoltaic technologies are further anticipated to positively influence India solar power products market during forecast period. Few Indian major players are as under Alectrona Energy Pvt. Ltd Alpex Solar Pvt. Ltd. Bright Solar Ltd. Central Electronics Ltd. Devsun Solar Pvt. Ltd
Plant capacity: Solar Panel:83.3 KW / dayPlant & machinery: 162 lakhs
Working capital: -T.C.I: Cost of Project : Rs 804 lakhs
Return: 28.00%Break even: 54.00%
Add to Inquiry Add to Inquiry Basket

Disposable Face Masks

A surgical mask, also known as a procedure mask, medical mask or simply as a face mask, is intended to be worn by health professionals during surgery and during nursing to catch the bacteria shed in liquid droplets and aerosols from the wearer's mouth and nose. They are not designed to protect the wearer from inhaling airborne bacteria or virus particles and are less effective than respirators, such as N95 or FFP masks, which provide better protection due to their material, shape and tight seal. Surgical masks are designed to keep operating rooms sterile, preventing germs from the mouth and nose of a wearer from contaminating a patient during surgery. Although they have seen a rise in popularity among consumers during outbreaks such as the coronavirus, surgical masks are not designed to filter out viruses, which are smaller than germs. The global market for surgical mask can be segmented on the basis of the following parameters: product, distribution channel, and region. On the basis product, the global surgical mask can be segmented into anti-fog surgical mask, basic surgical mask, fluid/splash resistant surgical mask, N95 mask, and others. Amongst these, the market for basic surgical mask has flown in from multiple healthcare facilities. The key distribution channels for surgical masks are drug stores, hospitals and clinics, and online stores. The effectiveness of surgical face mask in blocking the transmission of SARS is 68%. Therefore, it is widely used by medical workers as part of droplet transmission precaution when caring for patients with respiratory infections. Hence, increase in use of surgical face masks is projected to fuel the growth of the global surgical face masks market. Furthermore, vulnerable populations, such as older adults with chronic conditions, are at high risk of infectious diseases, including COVID-19. Hence, the use of face mask to prevent infections by the geriatric population is anticipated to drive the global market. The world is currently experiencing the pandemic of an infectious disease called COVID-19. This infection leads to multiple organ failure, acute & severe respiratory disorders, pneumonia, and even death in severe cases. Hence, surge in number of people with coronavirus infections is anticipated to drive the global surgical face masks market. According to the World Health Organization, globally, 823,626 confirmed and 72,736 new cases of COVID-19. Additionally, in the context of the novel coronavirus (2019-nCoV) outbreak, the World Health Organization recommends the use of masks in home and health care settings. This in turn increases demand for surgical marks. Hence, rise in demand for surgical masks is likely boost the growth of the global market. The use of face mask is vital to control infectious diseases, especially in circumventing droplet transmission. Few Indian major players are as under 3M India Ltd. Good Health Insurance T P A Ltd. Kimberly-Clark India Pvt. Ltd. Mediklin Healthcare Ltd. Surgeine Healthcare (India) Pvt. Ltd.
Plant capacity: Surgical Face Masks (each Pkts 25 Pcs.): 1,694 Pkts / day N95 Face Masks (each Pkts 5 Pcs.): 8,467 Pkts / dayPlant & machinery: 688 lakhs
Working capital: -T.C.I: Cost of Project: Rs 1400 lakhs
Return: 27.00%Break even: 58.00%
Add to Inquiry Add to Inquiry Basket

Hand Sanitizer

Hand sanitizers that do not contain alcohol usually contain benzalkonium chloride instead. They kill bacteria by disrupting their membranes, but we still don’t know how effective they are against certain types of viruses. The US Centre for Disease Control and Prevention say this type of hand sanitizer is less reliable for tackling Covid-19 than those which are alcohol-based. Hand sanitizer is a liquid or gel generally used to decrease infectious agents on the hands. Alcohol-based hand sanitizer kills many types of viruses by dissolving their fat membranes. It kills bacteria by disrupting its cell membrane. The product also usually contains hydrogen peroxide which kills bacterial spores. While older hand sanitizers were known to dry your hands, newer ones contain gelling agents which dramatically reduce skin dryness. Most of these hand sanitizers contain a combination of isopropyl alcohol (rubbing alcohol) and ethanol. The percentage of alcohol present in hand sanitizer is key to its efficacy – those with less than 60 per cent alcohol will be less effective at killing microorganisms, and will just reduce their growth. India hand sanitizer market is projected to surpass $ 43 million by 2025. Growth of hand sanitizer market in India can be attributed to rising awareness about healthy lifestyle & wellness, shifting consumer preference towards convenient hygiene products and rising disposable income. Moreover, the strong marketing activities by leading brands, in addition to huge endorsements, are some other drivers of hand sanitizer market in India. Moreover, the COVID-19 outbreak has boosted demand for sanitizers like never before across the diverse end user segments. The rising healthcare investments for providing a high-end and safer medical environment for healthcare professionals by preventing hospital-acquired infections (HAIs) have augmented the demand for hand sanitizers in the medical sector. Furthermore, as a result of the COVID-19 pandemic in the country, the demand of hand sanitizers has increased exponentially since the start of 2020. Growth of hand sanitizer market in India can be attributed to rising awareness about healthy lifestyle & wellness, shifting consumer preference towards convenient hygiene products and rising disposable income. Moreover, the strong marketing activities by leading brands, in addition to huge endorsements, are some other drivers of hand sanitizer market in India. Moreover, the COVID-19 outbreak has boosted demand for sanitizers like never before across the diverse end user segments. Hand Sanitizer Market size is projected to cross $2 billion by 2025, growing at a CAGR of 7.8% during the forecast period 2020-2025. Hand Sanitizer is an antiseptic disinfectant available in the form of a liquid, gel, foam and many others. It is said to be more effective than soaps due to its ability to eliminate most microorganisms. Public awareness campaigns by global health authorities such as the WHO (World Health Organization) also play a significant role in promoting the use of hand sanitizers. Increasing consumer awareness about hygiene coupled with such government initiatives are driving the hand sanitizer market. According to findings, there is a preference for using hand sanitizer by 77.0% of the population covered in a survey, while 23.0% claim to not to use the product. The 77.0% population in the favor of using hand sanitizer is comprised of 37.5% male users and 62.5% of female users. Moreover, key manufacturers are adding to their product line in order to increase their market share with increasing awareness. Few Indian major players are as under 3M India Ltd. Apollo Home Healthcare (India) Ltd. Colgate-Palmolive (India) Ltd. Dabur India Ltd. Godrej Hygiene Care Pvt. Ltd. [Merged] Himalaya Drug Co. Pvt. Ltd.
Plant capacity: Hand Sanitizer (50 ml size Bolltes):10,000 Bottles/dayPlant & machinery: Rs 16 lakhs
Working capital: -T.C.I: Cost of Project :Rs 156 lakhs
Return: 31.00%Break even: 62.00%
Add to Inquiry Add to Inquiry Basket

Surgical & N95 Masks

A surgical mask, also known as a procedure mask, medical mask or simply as a face mask, is intended to be worn by health professionals during surgery and during nursing to catch the bacteria shed in liquid droplets and aerosols from the wearer's mouth and nose. They are not designed to protect the wearer from inhaling airborne bacteria or virus particles and are less effective than respirators, such as N95 or FFP masks, which provide better protection due to their material, shape and tight seal. Surgical masks are designed to keep operating rooms sterile, preventing germs from the mouth and nose of a wearer from contaminating a patient during surgery. Although they have seen a rise in popularity among consumers during outbreaks such as the coronavirus, surgical masks are not designed to filter out viruses, which are smaller than germs. The India surgical mask market is driven by various factors, such as increase in elderly population, increase in adoption of surgical mask in the general population, and surge in prevalence of contagious and chronic diseases such as tuberculosis and asthma. Furthermore, rise in the number of medical device manufacturing companies is also anticipated to supplement the growth of the surgical masks industry. The world is currently experiencing the pandemic of an infectious disease called COVID-19. This infection leads to multiple organ failure, acute & severe respiratory disorders, pneumonia, and even death in severe cases. Hence, surge in number of people with coronavirus infections is anticipated to drive the global surgical face masks market. According to the World Health Organization, globally, 823,626 confirmed and 72,736 new cases of COVID-19 were recorded as of April 1, 2020. The effectiveness of surgical face mask in blocking the transmission of SARS is 68%. Therefore, it is widely used by medical workers as part of droplet transmission precaution when caring for patients with respiratory infections. Hence, increase in use of surgical face masks is projected to fuel the growth of the global surgical face masks market. Furthermore, vulnerable populations, such as older adults with chronic conditions, are at high risk of infectious diseases, including COVID-19. Hence, the use of face mask to prevent infections by the geriatric population is anticipated to drive the global market. Additionally, in the context of the novel coronavirus (2019-nCoV) outbreak, the World Health Organization recommends the use of masks in home and health care settings. This in turn increases demand for surgical marks. Hence, rise in demand for surgical masks is likely boost the growth of the global market. The use of face mask is vital to control infectious diseases, especially in circumventing droplet transmission. The India surgical mask market accounted for $58 million in 2017, and is projected to reach $95 million by 2025, registering a CAGR of 6.1% from 2018 to 2025. Surgical masks are made of natural fiber, such as cotton or disposable linen or synthetic materials, such as polypropylene. They are made of different layers including a hydrophobic outer layer, a middle filtering layer, and an inner hydrophilic layer to absorb the fluid and moisture. They are used as a barrier to avoid cross contamination by microorganisms and are used during surgical procedures. The surgical mask is used by surgeons during procedures and other medical professionals while interacting with the patients to avoid cross contamination of microorganisms. Thus, due to demand it is best to invest in this project. Few Indian major players are as under 3M India Ltd. Good Health Insurance T P A Ltd. Kimberly-Clark India Pvt. Ltd. Mediklin Healthcare Ltd. Surgeine Healthcare (India) Pvt. Ltd.
Plant capacity: 3-Layer Surgical Face Masks (each Pkts = 25 Pcs.) :380 Pkts / day N95 Face Masks (each Pkts = 5 Pcs.): 1,900 Pkts / dayPlant & machinery: Rs 166 lakhs
Working capital: -T.C.I: Cost of Project: Rs 266 lakhs
Return: 25.00%Break even: 66.00%
Add to Inquiry Add to Inquiry Basket

Spice Powder (Turmeric, Chilli, Pepper, Coriander and Cumin Powder)

Spices are woven into the history of nations. The desire to possess and monopolize the spice trade has, in the past, compelled manynavigators to find new routes to spice-producing nations. In the late 13thcentury, Marco Polo’s exploration of Asia established Venice as the most important trade port. Venice remained prosperous until about 1498. Portuguese explorer Vasco da Gama sailed around Africa’s Cape of Good Hope to reach Calicut, India. He returned with pepper, cinnamon, ginger and jewels, and also deals for the Portuguese to continue trade with India. India, known as the home of spices, boasts a long history of trading with the ancient civilisations of Rome and China. Today, Indian spices are the most sought-after globally, given their exquisite aroma, texture, taste and medicinal value. India has the largest domestic market for spices in the world. Traditionally, spices in India have been grown in small land holdings, with organic farming gaining prominence in recent times. India is the world's largest producer, consumer and exporter of spices; the country produces about 75 of the 109 varieties listed by the International Organization for Standardization (ISO) and accounts for half of the global trading in spices. Chilly is the largest produced spice in India. It contributed to the tune of ~% of the world production. This spice is used majorly in curried cuisines. It is also used in curry power, seasoning and other such spice mixes. MDH was the dominating player in FY’2015, with a market share of ~% in the total revenues generated from the sales of spices in the organized segment. The major factor for the dominance of MDH is the gigantic distribution network comprising of 1,000 wholesalers and more than 400,000 retailers in India. The Indian spices market is pegged at Rs. 40,000 crore annually, of which the branded segment makes up 15 per cent. According to Technopak, the branded space is dominated by national brands such as Catch, Everest, Ramdev, among others. The population in India is surging and the increasing consumer expenditure on food explains the swelling demand for food in India. Accordingly, the demand for spices is expected to grow in the future which will lead to a prominent growth in the revenues from the sales of spices in India. The revenues from India market are expected to expand to around USD 18 billion in FY’2020, growing with a CAGR of ~% from FY’2016 to FY’2020. The highest contribution to this growth is expected to come from the spice mixes and blended spices. The Indian spices market is worth INR 40,000 crore annually. Key spices produced in the country include pepper, cardamom, chilli, ginger, turmeric, coriander, cumin, celery, fennel, fenugreek, ajwain, dill seed, garlic, tamarind, clove, and nutmeg among others. The market is largely unorganized and the branded segment makes up about 15%. The branded market is dominated by players such as MTR, Badshaah, Catch, Everest, Ramdev etc. Recently, Tata Chemicals has launched its spices brand Tata Sampann Spices. Few Indian major players are as under A V T Mccormick Ingredients Pvt. Ltd. Akay Spices Pvt. Ltd. Bhavani Tea & Produce Co. Ltd. Cookme B B D Pvt. Ltd. D T A Amalgamated Foods Pvt. Ltd. Devon Foods Ltd. MDH Spices Oregon Spice Company
Plant capacity: Turmeric Powder :100.0 Kgs / day Red Chilli Powder:100.0 Kgs /day Pepper Powder: 100.0 Kgs / day Coriander Powder: 100.0 Kgs / day Cumin Powder:100.0 Kgs / dayPlant & machinery: Rs 12 lakhs
Working capital: -T.C.I: Cost of Project : Rs 38 lakhs
Return: 30.00%Break even: 75.00%
Add to Inquiry Add to Inquiry Basket

Active Pharma Ingredients (API) Amoxicillin Trihydrate, Azithromycin & Paracetamol

Active pharmaceutical ingredients are the active substances that are used in the manufacture of a drug and have a pharmacological effect. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. Azithromycin is used to treat certain bacterial infections, such as bronchitis; pneumonia; sexually transmitted diseases (STD); and infections of the ears, lungs, sinuses, skin, throat, and reproductive organs. Paracetamol is a commonly used medicine that can help treat pain and reduce a high temperature (fever). It is often recommended as one of the first treatments for pain, as it's safe for most people to take and side effects are rare. India is the seventh largest country in the world and has the second highest population. It has a parliamentary democratic form of government and has abundant natural resources and sufficient oil reserves. Huge investment promises from different countries predict a bright future for India. It has a well-developed administration and an independent judicial system with an ever-growing consumer base. It has a huge pool of hard-working skilled workers in all fields. The government has set up tax and non-tax incentives to establish new industrial entities in specific sectors, which include energy, ports, highways, electronics, and software. The Make in India initiative was launched by the government in 2014 and received an excellent response from the developed nations. The government has also created special areas dedicated to export, called export-processing zones (EPZs) or special economic zones (SEZs), to encourage foreign investment. The global active pharmaceutical ingredient market size is expected to reach a value of USD 286.6 billion by 2027, registering a CAGR of 6.7% over the forecast period. Factors, such as increasing preference for outsourcing APIs and growing prevalence of various target diseases such as cancer and Cardiovascular Diseases (CVDs) are expected to drive the market growth. Patent expirations of blockbuster drugs give rise to generic versions of these molecules, wherein the manufacturers bear the cost. After a patent expires, R&D investments done by the company are no longer beneficial for the company. API production requires a huge capital amount as the process needs extremely systematic protocols. Thus, pharmaceutical companies benefit from outsourcing API production, as it eliminates the need for labor force and installing expensive manufacturing units. Strategic outsourcing allows companies to focus on their core competencies, ultimately resulting in increased productivity. These factors are also projected to drive the active pharmaceutical ingredient market growth. The growth of active pharmaceutical ingredients market is marked by the huge demand for drugs like analgesics, anti-infectives and diabetes, and pain management drugs. But with the rising trend of increasing research and development (R&D) activities, the demand is experiencing a shift towards the advancement of complex APIs that find use in novel formulations, thereby targeting niche therapeutic areas. This facilitates the development of new technologies and ensures a high quality product. Among the problems for pharmaceutical supply chains during this pandemic are the restrictions and impact of COVID-19 on two of the largest global producers of active pharmaceutical ingredients (APIs) and generics: China and India. APIs is a crucial part of the pharma industry’s strategic plan to combat the COVID-19 pandemic. The majority of APIs for generic drug manufacturing across the globe are sourced from India, which also supplies approximately 30 percent of the generic APIs used in the US. However, Indian manufacturers rely heavily on APIs from China for the production of their medicine formulations, procuring around 70 percent from China, the top global producer and exporter of APIs by volume. Role of Government towards API The coronavirus outbreak disrupting supply of active pharmaceutical ingredients (APIs) and medical devices from China to India, the government has come out with four schemes worth Rs 13,760 crore to encourage manufacturing of bulk drugs and medical devices in the country and their exports. On March 21, the Union Cabinet under the chairmanship of Prime Minister Narendra Modi had approved an expenditure of Rs. 9,940 crore and Rs. 3,820 crore for APIs and medical devices, respectively. The Cabinet also approved a scheme on promotion of bulk drug parks for financing common infrastructure facilities in three bulk drug parks with financial implication of Rs. 3,000 crore for next five years. The government will give grants-in-aid to states with a maximum limit of Rs. 1,000 crore per bulk Drug Park. Parks will have common facilities such as solvent recovery plant, distillation plant, power and steam units, common effluent treatment plant etc. The government further approved production linked incentive (PLI) scheme for promotion of domestic manufacturing of critical KSMs/drug intermediates and APIs in the country with financial implications of Rs. 6,940 crore for next eight years. Financial incentive will be given to eligible manufacturers of identified 53 critical bulk drugs on their incremental sales over the base year (2019-20) for a period of 6 years. Out of 53 identified bulk drugs, 26 are fermentation based bulk drugs and 27 are chemical synthesis based bulk drugs. Rate of incentive will be 20 per cent (of incremental sales value) for fermentation based bulk drugs and 10 per cent for chemical synthesis based bulk drugs. The PLI scheme will lead to expected incremental sales of Rs. 46,400 crore and significant additional employment generation over eight years. The drug industry has welcomed the incentives offered by the government to promote API units in India. Besides APIs, the Cabinet also approved the scheme for promotion of medical device parks in the country in partnership with the states. A maximum grant-in-aid of Rs. 100 crore per park will be provided to the states. It will have financial implications of Rs. 400 crore. The PLI scheme for promoting domestic manufacturing of medical devices will have financial implications of Rs. 3,420 crore for next five years. Medical device is a growing sector and its potential for growth is the highest among all sectors in the healthcare market. It is valued at Rs. 50,026 crore for 2018-19 and is expected to reach to Rs. 86,840 crore by 2021-22. India depends on imports up to an extent of 85 per cent of total domestic demand of medical devices. Union Cabinet scheme on Promotion of Bulk Drug Parks • The scheme on Promotion of Bulk Drug Parks for financing Common Infrastructure Facilities in 3 Bulk Drug Parks with financial implication of Rs. 3,000 crore for next five years. • Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of critical KSMs/Drug Intermediates and APIs in the country with financial implications of Rs6,940 crore for next eight years. Details: Promotion of Bulk Drug Parks • Decision is to develop 3 mega Bulk Drug parks in India in partnership with States. • Government of India will give Grants-in-Aid to States with a maximum limit of Rs. 1000 Crore per Bulk Drug Park. • Parks will have common facilities such as solvent recovery plant, distillation plant, power & steam units, common effluent treatment plant etc. • A sum of Rs. 3,000 crore has been approved for this scheme for next 5 years. Production Linked Incentive Scheme • Financial incentive will be given to eligible manufacturers of identified 53 critical bulk drugs on their incremental sales over the base year (2019-20) for a period of 6 years. • Out of 53 identified bulk drugs, 26 are fermentation based bulk drugs and 27 are chemical synthesis based bulk drugs. • Rate of incentive will be 20 % (of incremental sales value) for fermentation based bulk drugs and 10% for chemical synthesis based bulk drugs. • A sum of Rs. 6,940 crore has been approved for next 8 years. Few Indian major players are as under Alpha Remedies Ltd Ankur Drugs & Pharma Ltd. Cian Healthcare Ltd Farmson Pharmaceutical Gujarat Pvt. Ltd. Glaxosmithkline Pharmaceuticals Ltd. Pan Drugs Ltd Piramal Enterprises Ltd.
Plant capacity: Paracetamol : 1,000.0 Kgs / day Azithromycin : 500.0 Kgs / day Amoxicillin Trihydrate: 500.0 Kgs dayPlant & machinery: 175 lakhs
Working capital: -T.C.I: Cost of Project : Rs 1322 lakhs
Return: 29.00%Break even: 47.00%
Add to Inquiry Add to Inquiry Basket

Manufacturing of Active Pharma Ingredients (API) (Amoxicillin Trihydrate, Azithromycin & Paracetamol).

Production of Active Pharma Ingredients (API) (Amoxicillin Trihydrate, Azithromycin & Paracetamol). Investment Opportunities in Pharmaceutical Industry. An active ingredient (AI) is that the ingredient in an exceedingly pharmaceutical drug that's biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active i.e. bulk medicine are utilized in medicine, and therefore the term active substance could also be used for natural products. Thus, depending on the drug’s administered dosage, the reactions and results differ. Certain drugs are comprised of more than one kind of API. Amoxicillin is an antibiotic used to treat variety of bacterial infections. These include middle ear infection, strep throat, pneumonia, skin infections, and tract infections among others. It’s taken orally, or less usually by injection. Active Pharmaceutical Ingredient (API), is that the term used to check with the biologically active component of a drug product (e.g. tablet, capsule). Drug products are typically composed of many elements. The aforementioned API is that the primary ingredient. Alternative ingredients are commonly known as "excipients" and these substances are always required to be biologically safe, often making up a variable fraction of the drug product. The procedure for optimizing and compositing this mixture of components utilized in the drug is known as "formulation." Paracetamol is a commonly used medicine that can help treat pain and reduce a high temperature (fever). It is often recommended as one of the first treatments for pain, as it's safe for most people to take and side effects are rare. Azithromycin is an antibiotic used for the treatment of variety of bacterial infections. This includes middle ear infections, strep throat, pneumonia, traveler's diarrhea, and bound alternative intestinal infections it also can be used for variety of sexually transmitted infections, as well as chlamydia and gonorrhea infections. At the side of alternative medications, it's going to even be used for malaria. It may be taken by mouth or intravenously with doses once per day. It is on the world Health Organization's List of Essential Medicines, the safest and most effective medicines required in a very health system. It’s one in all the most usually prescribed antibiotics in children. Trim ox is on the market as a generic medication. Related Books: - Pharmaceutical, Drugs, Proteins Technology Handbooks Azithromycin alone and in combination with different medications is currently being studied for the treatment of coronavirus wellness 2019 (COVID-19). Currently, azithromycin has been used with hydroxychloroquine to treat certain patients with COVID-19. However, there are mixed reports of effectiveness once azithromycin was used at the side of alternative medications to treat other viral respiratory infections. Azithromycin also has been used to treat bacterial infections in hospitalized patients with COVID-19. A lot of information is required before any conclusions may be made regarding the possible advantages and risks of using azithromycin either alone or together with hydroxychloroquine in patients with COVID-19. Amoxicillin Trihydrate may be a hydrate that's the Trihydrate type of amoxicillin; a semisynthetic antibiotic, used either alone or together with potassium clavulanate (under the name Augmentin) for treatment of a variety of bacterial infections. It’s a role as an antibacterial drug and an antimicrobial agent. It contains an amoxicillin. Manufacturing Process The manufacturing process of Paracetamol is summarized in the following steps: -charge acetic acid to the reactor. -add p-nitro phenol as a starting material and iron powder as catalyst. -Heat to temp 80-90 ºC. -The reaction is exothermic and temp will rise to 130 ºC. -After slight cooling -Reflux the reaction at 118ºC for 3-4 hours. -Cool to 60 ºC. -Add methanol to the reaction. -Reflux for 1 hour. -distill the methanol and recycle. -Add water to the obtained cake. -And make a solution -Add activated carbon. -Filter -Dry the cake. -Pulverize the dry cake to get the Paracetamol fine powder. Applications:- Communicable Diseases Oncology Diabetes Cardiovascular Diseases Pain Management Respiratory Diseases Other Therapeutic Applications Role of Government towards API The coronavirus outbreak disrupting supply of active pharmaceutical ingredients (APIs) and medical devices from China to India, the government has come out with four schemes worth Rs 13,760 crore to encourage manufacturing of bulk drugs and medical devices in the country and their exports. On March 21, the Union Cabinet under the chairmanship of Prime Minister Narendra Modi had approved an expenditure of Rs. 9,940 crore and Rs. 3,820 crore for APIs and medical devices, respectively. The Cabinet also approved a scheme on promotion of bulk drug parks for financing common infrastructure facilities in three bulk drug parks with financial implication of Rs. 3,000 crore for next five years. The government will give grants-in-aid to states with a maximum limit of Rs. 1,000 crore per bulk Drug Park. Parks will have common facilities such as solvent recovery plant, distillation plant, power and steam units, common effluent treatment plant etc. The government further approved production linked incentive (PLI) scheme for promotion of domestic manufacturing of critical KSMs/drug intermediates and APIs in the country with financial implications of Rs. 6,940 crore for next eight years. Financial incentive will be given to eligible manufacturers of identified 53 critical bulk drugs on their incremental sales over the base year (2019-20) for a period of 6 years. Out of 53 identified bulk drugs, 26 are fermentation based bulk drugs and 27 are chemical synthesis based bulk drugs. Rate of incentive will be 20 per cent (of incremental sales value) for fermentation based bulk drugs and 10 per cent for chemical synthesis based bulk drugs. The PLI scheme will lead to expected incremental sales of Rs. 46,400 crore and significant additional employment generation over eight years. The drug industry has welcomed the incentives offered by the government to promote API units in India. Besides APIs, the Cabinet also approved the scheme for promotion of medical device parks in the country in partnership with the states. A maximum grant-in-aid of Rs. 100 crore per park will be provided to the states. It will have financial implications of Rs. 400 crore. The PLI scheme for promoting domestic manufacturing of medical devices will have financial implications of Rs. 3,420 crore for next five years. Medical device is a growing sector and its potential for growth is the highest among all sectors in the healthcare market. It is valued at Rs. 50,026 crore for 2018-19 and is expected to reach to Rs. 86,840 crore by 2021-22. India depends on imports up to an extent of 85 per cent of total domestic demand of medical devices. Union Cabinet scheme on Promotion of Bulk Drug Parks • The scheme on Promotion of Bulk Drug Parks for financing Common Infrastructure Facilities in 3 Bulk Drug Parks with financial implication of Rs. 3,000 crore for next five years. • Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of critical KSMs/Drug Intermediates and APIs in the country with financial implications of Rs6,940 crore for next eight years. Details: Promotion of Bulk Drug Parks • Decision is to develop 3 mega Bulk Drug parks in India in partnership with States. • Government of India will give Grants-in-Aid to States with a maximum limit of Rs. 1000 Crore per Bulk Drug Park. • Parks will have common facilities such as solvent recovery plant, distillation plant, power & steam units, common effluent treatment plant etc. • A sum of Rs. 3,000 crore has been approved for this scheme for next 5 years. Production Linked Incentive Scheme • Financial incentive will be given to eligible manufacturers of identified 53 critical bulk drugs on their incremental sales over the base year (2019-20) for a period of 6 years. • Out of 53 identified bulk drugs, 26 are fermentation based bulk drugs and 27 are chemical synthesis based bulk drugs. • Rate of incentive will be 20 % (of incremental sales value) for fermentation based bulk drugs and 10% for chemical synthesis based bulk drugs. • A sum of Rs. 6,940 crore has been approved for next 8 years. Market Outlook Active Pharmaceutical Ingredient Market is valued at USD 172.69 Billion in 2018 and expected to reach USD 263.80 Billion by 2025 with the CAGR of 6.24% over the forecast period. The increasing incidence of chronic diseases, growing importance of generics, and the increasing uptake of biopharmaceuticals are some of the major factors driving the growth of the global APIs market. On the other hand, the unfavorable drug price control policies across various countries and the increasing penetration of counterfeit drugs are expected to restrain the growth of this market in the coming years. Related Projects: - Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates Drugs and over-the-counter (OTC) drugs. In 2019, the prescribed drugs segment is expected to account for the most important share of the APIs market. The demand for drugs falling under this class has increased significantly in recent years because of the rising prevalence of target diseases. Additionally, the most important share of the prescription drugs segment also can be attributed to the increased focus of innovator corporations on the development of specialty drugs and affordability of health care. The implementation of significant federal reforms to improve the affordability of healthcare, especially in the, us has expanded the consumption of each traditional and specialty medicine. Also, inflation has played a key role in enhancing revenue from the sales of prescription drugs, significantly specialty drugs. All these factors are collectively responsible for the large share of this phase. Based on the kind of drug, the APIs market can be classified into two segments prescribed. Manufacturer Insights On the basis of type of manufacturer, the API market has been segmented into merchant and captive APIs. Captive API command the most important share in 2019 because of simple availability of raw materials and intensive capitalization of major key players for the development of high-end manufacturing facilities. API is calculable to be the fastest-growing segment over the forecast period. The segment growth is driven by factors similar to high cost of in-house manufacturing of those molecules and rising demand for biopharmaceuticals. Related Videos: - Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Pharmaceutical Bulk Drugs Active Pharmaceutical Ingredient (APIs) are portions of any drugs that are biologically active in nature. The APIs have significant use in the manufacturing of effective and safe medicines. Depending on the drug’s administered dosage, the reactions and results take issue according to the requirement and use for specific treatment of diseases. Sure medicine are contained of over one kind of API. medicine are chosen primarily for his or her active ingredients to treat variety of chronic and infectious diseases similar to diabetes, cancer, arthritis, bone & joint infections, pneumonia, otitis, streptococcal pharyngitis, cellulites, and tract infections. However, the standard will vary widely from one whole to a different. Medicine are chosen primarily from active ingredients within the liquid or solid form like tablet or alternative throughout. Global Active Pharmaceutical Ingredient Market Dynamics The key issue for growth of worldwide Active Pharmaceutical Ingredient market is that the rise of demand for the new drug discovery for treatment of various chronic and infectious diseases like HIV, cancer, arthritis, bone & joint infections, hepatitis-B, Aids etc. across the world. According to WHO in 2018, the worldwide cancer burden has up to 18.1 million new cases as well as 9.6 million deaths across the world. Because of such rise within the cases of cancer, the new drugs discovery using the Active Pharmaceutical Ingredient has become essential. Recently in line with the American Chemical Society in 2019, there has been 48 new drugs has been approved by the fad U.S. out of that 11 for new cancer treatments with the innovative molecular pharmaceutical ingredients. However, the Active Pharmaceutical Ingredient market is hampered by would like for prime investment with huge capital demand for research and developments. Moreover rising health cautiousness among the people with technological advancement immense investment for launching of recent drugs and biological products, acquisitions, collaborations, and regional growth can provide huge opportunity for Active Pharmaceutical Ingredient market. For instance in 2019, Raquel has been acquired by Merck & Co. for roughly around USD 2.7 billion in cash, for making cancer drug using Active Pharmaceutical Ingredient with the most recent small-molecule-focused. Expansion of Manufacturing Facilities Creating Lucrative Opportunities for Market Growth Majority of specialty API companies are increasing their manufacturing facilities for specialty active pharmaceutical ingredients (API) to take care of or gain market share. Substantial investments within the growth of approved specialty active pharmaceutical ingredients (API) is one in all the most important factors among key players in the specialty active pharmaceutical ingredients (API) market. For instance, in early 2020, Wuxi STA opened oligonucleotide API manufacturing facility in Changzhou, China to cope up with the increasing demand. In 2018, Cordon Pharma expanded operations with new commercial oligonucleotide active pharmaceutical ingredients (API) manufacturing capabilities at its FDA inspected Colorado facility. The emergence of COVID-19 has brought the world to a standstill. We perceive that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies will help within the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost each sector is anticipated to be impacted by the pandemic. Focus on healthcare to drive the active pharmaceutical ingredients market The spending on healthcare has grown at a rapid pace in recent years and it increased at a CAGR of 6.92% between the years 2003 and 2013. The healthcare spending growth was significantly higher than the population growth rate that grew at a CAGR of 1.22% for the same period. The per capita healthcare spending rose from just under US$ 600 in 2003 to above US$ 1000 in 2013, at an average CAGR of 5.62%. The focus on healthcare spending was observed to be a global phenomenon and this directly benefited the active pharmaceutical ingredients market. Related Videos: - Active Pharma Ingredients (API) - Global Market Estimated to Reach US$ 21.9 billion by 2023 Investment Opportunities in API Bulk Drugs & Intermediates Manufacturing Unit Production of Paracetamol (Acetaminophen), bulk pharmaceutical active ingredient Investment Opportunities in APIs KSMs Drug Intermediates Bulk Drug Industries Manufacturing Business Ideas in Pharmaceutical Industry Key Players Pfizer, Inc. (US), Novartis AG (Switzerland), Sanofi (France), Boehringer Ingelheim (Germany), Bristol-Myers Squibb (US), Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly and Company (US), GlaxoSmithKline plc (UK), Merck & Co., Inc. (US), AbbVie Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), and AstraZeneca plc (UK). Sun Pharmaceutical Industries Ltd. Tags:- #Activepharmaingredients #pharmaingredients #IndianPharma #medicineingredients #paracetamolingredients #amoxicillinTrihydrate #Azithromycin #COVID19 #Paracetamol #coronavirus #CoronavirusBusiness #COVID2019 #CaronaBUSINESS #lockdownbusiness #businessinlockdown #coronavirusbusiness #Entrepreneurs #covid19business #DetailedProjectReport #businessconsultant #BusinessPlan #feasibilityReport #NPCS #industrialproject #entrepreneurindia #startupbusiness #startupbusinessideas #businessestostart #startupideas #startupbusinesswithnomoney #businessstartupindia #API
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Red Oxide Primer

A primer is a preparatory coating put on materials before painting. Priming ensures better adhesion of paint to the surface, increases paint durability, and provides additional protection for the material being painted. A primer designed for metal is still highly recommended if a part is to be exposed to moisture. Once water seeps through to the bare metal, oxidation will begin (plain steel will simply rust). Metal hydroxides/oxides do not provide a solid surface for the paint to adhere to, and paint will come off in large flakes. Using a primer will provide extra insurance against such a scenario. Primer is a term used to describe a number of substances that consist of a Red Oxide suspended in a liquid or paste vehicle such as oil or water. With a brush, a roller, or a spray gun, primer is applied in a thin coat to various surfaces such as wood, metal, or stone. Although it’s primary purpose is to protect the surface to which it is applied. Red oxide primer is a specially formulated coating used as a base coat for ferrous metals. Red-oxide primer serves a similar purpose to interior wall primers in that it prepares metal for a topcoat, but it also gives iron and steel surfaces a layer of protection. A primer is composed of Red Oxide, solvents, resins, and various additives. The pigments give the primer color; solvents make it easier to apply; resins help it dry; and additives serve as everything from fillers to anti fungicidal agents. Other additives produce certain desired characteristics. in primer such as the thixotropic agents that give primer its smooth texture, driers, anti-settling agents, anti-skinning agents, defoamers, and a host of others that enable primer to cover well and last long. Red oxide primer is the commonly used in metal primers. Red oxide is excellent for exposure to sunlight and exterior exposure. The Indian paint industry has been growing at an average 15% per annum over the last decade. Growth has been consistent with the Indian GDP growth rate and in some years the industry has grown at a rate of 1.5 to 2 times higher than that of GDP growth. Construction remains the key growth sector and is driving demand for decorative and protective coatings. The sector accounts for nearly 45% of the total national investment in infrastructure and the trend is expected to continue in the future. Many paint companies are expanding their operations in India but the rapid growth of the paint industry, with billions of rupees being invested in enhancing capacities, is causing concern among environmentalists. India is also the second largest paint market in Asia with an annual demand of over two million tonnes, again second only to China. Moreover, due to the low per capita consumption of paints in India. The paint industry can easily grow at 12-13% annually over the next few years from its current size of Rs 350 bn. The per capita paint consumption in India which is a little over 4 kegs is still very low as compared to the developed western nations. Therefore, as the country develops and modernizes, the per capita paint consumption is bound to increase. The unorganized sector controls around 35% of the paint market, with the organized sector accounting for the balance. This is due to increasing demand from retail consumers, on rapid urbanization, and development of rural markets. The industry will reach the level of Rs 62,000 crore in the next two years, it said. A rise in disposable income of the average middle class coupled with increasing investment on education, urbanization, development of the rural market and various launches of many innovative products will be major drivers, it said. India is the second largest consumer of paint in Asia. Few Indian major players are as under Asian Paints Ltd. B A S F India Ltd. Berger Paints India Ltd. Chowgule A B P Coatings (India) Pvt. Ltd. Gunjan Paints Ltd. Lona Industries Ltd Mallak Oilchem Pvt. Ltd.
Plant capacity: Red Oxide Primer (Each Packed in 20 Ltrs Container):500.0 Packs / day Plant & machinery: Rs 151 lakhs
Working capital: -T.C.I: Cost of Project:Rs 365 lakhs
Return: 28.00%Break even: 55.00%
Add to Inquiry Add to Inquiry Basket

Disposable Nitrile Gloves

Nitrile gloves are a type of disposable gloves made from synthetic rubber, this means there is no risk of latex allergies. They are the most popular gloves type in our range and offer superior strength, dexterity and resistance to oils and aqueous chemicals in comparison to vinyl or latex. For these reasons, they are often used in the medical, laboratory and manufacturing industries. Nitrile gloves are a great compromise between latex and vinyl. Our Blue Nitrile gloves offer protection from bodily fluids providing a barrier that prevents infection, cross-infection or cross-contamination. Tests revealed that Nitrile gloves are three times more puncture-resistant than rubber gloves. Nitrile gloves protect the wear from a range of chemicals and blood borne pathogens. Our Nitrile Gloves go through an extra process of chlorinating which ease donning. Made from allergy safe compound that feels like latex, but stronger, cheaper and more comfortable. Nitrile exam gloves are the material of choice for many professional users because of its cut resistance, chemical resistance, cost, allergy safe and cleanliness. Indian glove market is growing at 15% while the demand for examination gloves has been rising by 20%per annum. St Mary’s is the largest supplier of centrifugal latex under the brand Cenex, a crucial raw material for manufacturing rubber dipped goods like gloves, balloons, condoms and rubber bands Impact of COVID-19 Impact of COVID-19 on the Worldwide Disposable Gloves Industry to 2025 The global disposable gloves market is highly competitive. Innovations, sustainability, and regulatory adherence constitute three pillars for the disposable gloves market success. Factors such as the growth in the aging population, awareness of infection prevention standards, and expansion of healthcare infrastructure are the major factors contributing to market growth. However, growth in medical tourism, advancement in surgical techniques and medical equipment, increase in public and private investments and government initiatives, the onset of pandemic diseases, and the rise in chronic diseases are other drivers stimulating the demand for disposable gloves. The demand for medical gloves has surged up rapidly in countries such as the UK, China, the US, India, Iran, and Italy due to the outbreak of the COVID-19 pandemic. The disease has increased the importance of hygiene among individuals. The market landscape of disposable gloves, which are fast turning into retail commodities, is expected to be accelerated. When a person touches an object/surface contaminated by COVID-19 infected person, and then touches his own eyes, nose, or mouth, he may get exposed to the virus. Although this is not thought to be a predominant mode of transmission, care should be exercised while handling objects/surface potentially contaminated by suspect/confirmed cases of COVID-19. India disposable gloves market generated $303 million in 2017, and is projected to reach $760 million by 2025, growing at a CAGR of 12.4% from 2018 to 2025. In terms of volume, the market is growing at a CAGR of 8.3% from 2018 to 2025. Few Indian major players are as under Honeywell International (India) Pvt. Ltd. London Rubber India Ltd. Mallcom (India) Ltd. Sara Healthcare Pvt. Ltd. T T K Biomed Ltd. Wellness Forever Medicare Pvt. Ltd.
Plant capacity: Disposable Nitrile Gloves:100,000.0 Pcs. / dayPlant & machinery: Rs 632 lakhs
Working capital: -T.C.I: Cost of Project : Rs 1239 lakhs
Return: 29.00%Break even: 57.00%
Add to Inquiry Add to Inquiry Basket

Information
  • One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
  • One Crore is equivalent to ten million (10,000,000)
  • T.C.I is Total Capital Investment
  • We can modify the project capacity and project cost as per your requirement.
  • We can also prepare project report on any subject as per your requirement.
  • Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Page 160 of 161 | Total 1602 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 .... 160 161   Next »

About NIIR PROJECT CONSULTANCY SERVICES

Hide »

NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.

Our various services are: Detailed Project Report, Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Selection of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.

NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.

^ Top